Bayer
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Bayer was mentioned 36 times in 13 outlets across 4 countries over the last 12 months. 31% of that coverage was positive and 0% negative. 86% was editorial rather than PR or paid placement.
MENTIONS · 12M
36
38 all-time
OUTLETS · 12M
13
in 4 countries
AVG SENTIMENT
+0.203
EDITORIAL
86%
5 PR · 31 editorial
Recent coverage
Living Security Announces HRMCon 2026 Speaker Lineup - ACCESS Newswire
accessnewswire.com · INT · 31 Aug 2026 · positive
Bayer's Cardiology Offensive: New Data Points and a Diagnostic Wildcard Reshape the Investment Case - ad-hoc-news.de
ad-hoc-news.de · DE · 31 Aug 2026 · neutral
Weekly Recap: Eighth Circuit upholds Roundup and Kerendia Japan filing - TradingView
tradingview.com · JP · 31 Aug 2026 · positive
Resilient Bayer stock holds above EUR 48 as Kerendia trial data and REVEAL study update highlight pi - AD HOC NEWS
ad-hoc-news.de · DE · 30 Aug 2026 · positive
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026 - Yahoo Finance
finance.yahoo.com · INT · 20 Aug 2026 · positive
Bayer Aktie: Deutsche Bank vs. Jefferies – 14 Euro Spread
boerse-express.com · INT · 16 Aug 2026 · neutral
Bayer, Simplot Reshape Distribution Relationship Ahead of 2027 Season - thedailyscoop.com
thedailyscoop.com · INT · 6 Aug 2026 · positive
Bayer files a WARN notice for employees affected by farm operation consolidations on Maui and Oʻahu - Maui Now
mauinow.com · INT · 23 Jul 2026 · neutral
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 1 |
| 2026-01 | 0 |
| 2026-02 | 0 |
| 2026-03 | 1 |
| 2026-04 | 0 |
| 2026-05 | 3 |
| 2026-06 | 19 |
| 2026-07 | 5 |
| 2026-08 | 7 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Bayer against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page